Family involvement in cognitive behavioral therapy for OCD
Impact of Involvement of the Family in the Cognitive Behavioral Group Therapy for Obsessive-Compulsive Disorder: a Randomized Controlled Trial.
This study is testing whether including family members in group therapy can help people with OCD feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Trial ID | NCT04071990 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of involving family members in cognitive behavioral group therapy (CBGT) for patients with obsessive-compulsive disorder (OCD). It aims to assess how family participation can influence OCD symptoms, family accommodation, and overall quality of life over a 12-week treatment period. Eighty patients aged 18-65 with a confirmed OCD diagnosis will be paired with their live-in family members, who will also participate in the therapy sessions. The study will utilize randomization to compare standard CBGT with family-involved CBGT.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with a diagnosis of OCD and a minimum score of 16 on the Yale-Brown Obsessive Compulsive Scale.
Not a fit: Patients with severe suicidality, substance abuse issues, psychotic symptoms, or those currently receiving deep brain stimulation for OCD may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment outcomes for OCD patients by reducing symptoms and enhancing family dynamics.
How similar studies have performed: Previous studies have shown promising results for family involvement in therapy for OCD, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * the OCD patient with a score of at least 16 on Y-BOCS * patient and family member fluent in Dutch * patient and family member both willing to attend all treatment sessions together. Exclusion Criteria: * current severe suicidality * current substance abuse * psychotic symptoms and * OCD treated with deep brain stimulation
Where this trial is running
Ghent
- Ghent University Hospital — Ghent, Belgium (Recruiting)
Study contacts
- Principal investigator: Gilbert MD Lemmens, MD, PhD — Ghent University Hospital, University Ghent
- Study coordinator: Hannelore LN Tandt, MD
- Email: hannelore.tandt@uzgent.be
- Phone: +3293324394
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.